HCPCS Level II · Drugs administered other than oral method
J1746Injection, ibalizumab-uiyk, 10 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1746
J1746 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, ibalizumab-uiyk, 10 mg.
It was added to HCPCS effective 01/01/2019.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj., ibalizumab-uiyk, 10 mg
- Date added
- 01/01/2019
- Action effective
- 01/01/2019
- BETOS
- O1E
Related J17xx codes
- J1700Injection, hydrocortisone acetate, up to 25 mg
- J1720Injection, hydrocortisone sodium succinate, up to 100 mg
- J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730Injection, diazoxide, up to 300 mg
- J1736Injection, meloxicam (delova), 1 mg
- J1737Injection, meloxicam (azurity), 1 mg
- J1738Injection, meloxicam, 1 mg
- J1740Injection, ibandronate sodium, 1 mg
- J1741Injection, ibuprofen, 100 mg
- J1742Injection, ibutilide fumarate, 1 mg
- J1743Injection, idursulfase, 1 mg
Common questions about J1746
Is HCPCS J1746 still valid?
- Yes. J1746 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J1746?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.